gusperimus and methylprednisolone
gusperimus has been researched along with methylprednisolone in 30 studies
Research
Studies (30)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 25 (83.33) | 18.2507 |
2000's | 4 (13.33) | 29.6817 |
2010's | 1 (3.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Ishibashi, M; Jiang, H; Kameoka, H; Kokado, Y; Moutabarrik, A; Okuyama, A; Sonoda, T; Takahara, S; Takano, Y | 1 |
Amemiya, H; Dohi, K; Endo, T; Fukao, K; Hirano, T; Ishibashi, M; Kurita, T; Nagano, S; Otsubo, O; Sato, K | 1 |
Amemiya, H; Fukuoka, T; Hayashi, R; Kenmochi, T; Niiya, S; Suzuki, S | 1 |
Cooper, DK; Human, PA; Reichart, B; Reichenspurner, H; Rose, AG | 1 |
Agishi, T; Ito, K; Kawaguchi, H; Oba, S; Ota, K; Takahashi, K; Tanabe, K; Teraoka, S; Toma, H | 1 |
Hiraoka, A | 1 |
Fujimoto, N; Fukunishi, Y; Hanafusa, T; Ichikawa, Y; Ihara, H; Ishibashi, M; Kyo, M; Nagano, S; Okuyama, A; Takahara, S | 1 |
Furuhashi, K; Kozaki, K; Kozaki, M; Matsuno, N; Miyamoto, K; Saito, A; Sakurai, E; Tamaki, I; Yoshida, M | 1 |
Amemiya, H; Hayashi, R; Nakatani, T; Suzuki, S | 1 |
Amemiya, K; Inoue, K; Kamata, K; Kobayashi, N; Masaki, Y; Okubo, M | 1 |
Hirano, T; Kono, K; Kozaki, K; Kozaki, M; Matsuno, N; Oka, K; Sakurai, E; Tamaki, T; Tanaka, M; Uchiyama, M | 1 |
Endo, T; Go, M; Kamata, K; Kumano, K; Nakayama, Y; Okubo, M; Osakabe, T; Sato, K; Tamura, K; Tsukamoto, Y | 1 |
Ishibashi, M; Kameoka, H; Kokado, Y; Moutabarrik, A; Okuyama, A; Sonoda, T; Takahara, S; Takano, Y; Zaid, D | 1 |
Akiyama, T; Amemiya, H; Fukunishi, T; Hanafusa, T; Ichikawa, Y; Ihara, H; Ito, K; Kokado, Y; Kurita, T; Kyo, M; Nagano, S; Okuyama, A; Sagawa, S; Sonoda, T; Suzuki, S; Takahara, S | 1 |
Amemiya, H; Kakefuda, T; Koyama, I; Kozaki, K; Kyo, M; Sakamoto, K; Yuzawa, K | 1 |
Imai, Y; Moizumi, Y; Sakurai, M; Tabayashi, K; Uchida, S | 1 |
Katagiri, A; Nakagawa, Y; Saito, K; Sonda, K; Takahashi, K; Takeda, M; Tanigawa, T; Tomita, Y | 1 |
Aikawa, A; Arai, K; Fushimi, T; Hadano, T; Hasegawa, A; Hirayama, N; Mizuiri, T; Ohara, T; Sakai, K; Shindo, M; Tajima, E; Yamashita, M | 1 |
Ichimaru, N; Inoue, T; Kameoka, H; Kokado, Y; Kyakuno, M; Kyo, M; Miyamoto, M; Nakamura, T; Nanba, Y; Okuyama, A; Takahara, S; Toki, K; Wang, DJ | 1 |
Amada, N; Miura, S; Ohashi, Y; Okazaki, H; Sato, T | 1 |
Ichimaru, N; Kokado, Y; Kyo, M; Miki, T; Okuyama, A; Takahara, S; Toki, K; Wang, JD | 1 |
Ando, Y; Beck, Y; Kikuchi, K; Meigata, K; Nishimura, Y; Nomura, Y; Tomikawa, S | 1 |
Asahara, T; Dohi, K; Fudaba, Y; Fukuda, Y; Marubayashi, S; Miyata, Y; Ohdan, H; Shibata, S; Shintaku, S; Yamamoto, H | 1 |
Fuchinoue, S; Goya, N; Harano, M; Inui, M; Ishikawa, N; Nakazawa, H; Otsubo, S; Suzuki, K; Tanabe, K; Tokumoto, T; Toma, H; Yagisawa, T | 1 |
Fuchinoue, S; Harano, M; Ichikura, H; Inui, M; Ishikawa, N; Ito, S; Manu, M; Okuda, H; Shimmura, H; Shimuzu, T; Tanabe, K; Tokumoto, T; Toma, H; Yagisawa, T | 1 |
Fuchinoue, S; Harano, M; Inui, M; Ishikawa, N; Ito, S; Manu, M; Ohtsubo, S; Okuda, H; Shimizu, T; Shimmura, H; Shiroyanagi, Y; Tanabe, K; Tokumoto, T; Toma, H; Yagisawa, T | 1 |
Chubachi, S; Doi, H; Haga, I; Kawagishi, N; Kikuchi, H; Koyamada, N; Nakajima, N; Oguma, S; Ohkohchi, N; Orii, T; Satomi, S; Sekiguchi, S | 1 |
Amemiya, H; Kido, K; Nakano, H; Suzuki, S | 1 |
Aiso, T; Akamatsu, Y; Fujimori, K; Hukushima, K; Kawagishi, N; Miyagi, S; Nakanishi, C; Sato, A; Sato, K; Satomi, S; Sekiguchi, S; Takeda, I | 1 |
Ito, S; Kamei, K; Matsuoka, K; Okada, M | 1 |
Trials
7 trial(s) available for gusperimus and methylprednisolone
Article | Year |
---|---|
Markedly enhanced therapeutic effect of deoxyspergualin on acute rejection when combined with methylprednisolone in kidney recipients.
Topics: Drug Therapy, Combination; Graft Rejection; Guanidines; Humans; Immunosuppression Therapy; Kidney Transplantation; Methylprednisolone; Time Factors | 1991 |
Histopathological classification and clinical effects of kidney transplant rejection treated with 15-deoxyspergualin.
Topics: Adult; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Graft Rejection; Guanidines; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone | 1995 |
15-Deoxyspergualin "rescue therapy" for methylprednisolone-resistant rejection of renal transplants as compared with anti-T cell monoclonal antibody (OKT3).
Topics: Adult; Creatinine; Drug Resistance; Female; Graft Rejection; Guanidines; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Muromonab-CD3; Salvage Therapy | 1993 |
Tacrolimus therapy for ABO-incompatible kidney transplantation.
Topics: ABO Blood-Group System; Adult; Antilymphocyte Serum; Azathioprine; Blood Group Incompatibility; Drug Therapy, Combination; Graft Rejection; Graft Survival; Guanidines; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Survival Rate; Tacrolimus | 1998 |
ABO incompatible kidney transplantation on triple therapy compared with quadruple therapy.
Topics: ABO Blood-Group System; Adult; Antilymphocyte Serum; Azathioprine; Blood Group Incompatibility; Cyclophosphamide; Cytomegalovirus Infections; Drug Therapy, Combination; Female; Guanidines; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Postoperative Complications; Prognosis | 1998 |
Beneficial effects of 15-deoxyspergualin on late acute rejection occurring more than three months after renal transplantation.
Topics: Antilymphocyte Serum; Follow-Up Studies; Graft Rejection; Graft Survival; Guanidines; Humans; Immunosuppressive Agents; Incidence; Kidney Transplantation; Methylprednisolone; Recurrence; Time Factors | 1998 |
Effect of deoxyspergualin on acute and chronic rejection in renal transplantation.
Topics: Acute Disease; Adult; Azathioprine; Child; Child, Preschool; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Guanidines; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Prednisolone; Ribonucleosides | 1998 |
Other Studies
23 other study(ies) available for gusperimus and methylprednisolone
Article | Year |
---|---|
Experience with administration of 15-deoxyspergualin in rejection in kidney transplant recipients.
Topics: Adult; Creatinine; Cyclosporine; Female; Graft Rejection; Guanidines; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Ribonucleosides; Time Factors; Treatment Outcome | 1992 |
Remarkable recovery from rejection by treatment with deoxyspergualin and methylprednisolone on canine kidney allografts.
Topics: Animals; Creatinine; Dogs; Drug Therapy, Combination; Graft Rejection; Guanidines; Immunosuppressive Agents; Kidney Transplantation; Methylprednisolone; Transplantation, Homologous | 1991 |
Effect of pharmacologic immunosuppression on donor heart survival in a closely related nonhuman primate xenograft model.
Topics: Animals; Antilymphocyte Serum; Azathioprine; Chlorocebus aethiops; Cyclosporins; Dose-Response Relationship, Drug; Graft Rejection; Guanidines; Heart Transplantation; Immunosuppressive Agents; Lymphatic Irradiation; Methylprednisolone; Papio; Transplantation, Heterologous | 1990 |
Effect of a novel immunosuppressive agent, deoxyspergualin, on rejection in kidney transplant recipients.
Topics: Azathioprine; Cyclosporins; Drug Therapy, Combination; Female; Graft Rejection; Guanidines; Histocompatibility Testing; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Ribonucleosides | 1990 |
[Control of graft-vs-host disease].
Topics: Adolescent; Adult; Bone Marrow Transplantation; Female; Graft vs Host Disease; Guanidines; Humans; Leucine; Leukemia; Male; Methylprednisolone; Ribonucleosides | 1990 |
Effectiveness of 15-deoxyspergualin on renal graft rejection.
Topics: Acute Disease; Adult; Chronic Disease; Drug Therapy, Combination; Female; Graft Rejection; Guanidines; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone | 1994 |
Long-term outcome of cadaveric kidney grafts with triple drug therapy.
Topics: Cadaver; Cyclosporine; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Graft Survival; Guanidines; Humans; Immunosuppressive Agents; Kidney Transplantation; Methylprednisolone; Retrospective Studies; Ribonucleosides; Survival Analysis; Time Factors; Tissue Donors; Treatment Outcome | 1994 |
High-dose 15-deoxyspergualin monotherapy surpasses methylprednisolone in its therapeutic effect on advanced lupus nephritis in New Zealand black/white F1 hybrid mice, and low-dose combination may be synergistic.
Topics: Animals; Drug Synergism; Drug Therapy, Combination; Female; Guanidines; Hybridization, Genetic; Lupus Nephritis; Methylprednisolone; Mice; Mice, Inbred NZB | 1993 |
Implications of lymphocyte sensitivity to glucocorticoids in renal transplant recipients.
Topics: Acute Disease; Adult; Azathioprine; Blood Transfusion; Cyclosporine; Graft Rejection; Guanidines; Histocompatibility Testing; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Lymphocytes; Methylprednisolone; Monitoring, Immunologic; Prednisolone; Prognosis | 1993 |
Use of 15-deoxyspergualin in treatment of acute rejection in kidney transplant patients.
Topics: Acute Disease; Adult; Chronic Disease; Cyclosporine; Female; Follow-Up Studies; Graft Rejection; Guanidines; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Ribonucleosides; Time Factors | 1993 |
Results with histological diagnosis in kidney transplant rejections treated with 15-deoxyspergualin.
Topics: Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Guanidines; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Retrospective Studies; Ribonucleosides; Tacrolimus; Time Factors | 1996 |
Outline and long-term prognosis in 15-deoxyspergualin-treated cases. Japan Collaborative Transplant Study Group of NKT-01.
Topics: Acute Disease; Graft Rejection; Graft Survival; Guanidines; Humans; Immunosuppressive Agents; Kidney Transplantation; Methylprednisolone; Prognosis; Retrospective Studies; Time Factors | 1996 |
Transfusion-associated graft-versus-host disease in immunocompetent patient: early diagnosis and therapy.
Topics: Aged; Aortic Aneurysm; Aortic Dissection; Cyclosporine; DNA; Glucocorticoids; Graft vs Host Disease; Guanidines; Humans; Immunocompetence; Immunosuppressive Agents; Male; Methylprednisolone; Microsatellite Repeats; Polymorphism, Genetic; Time Factors; Transfusion Reaction | 1998 |
[Histopathological findings and clinical effects for acute rejections].
Topics: Acute Disease; Antilymphocyte Serum; Graft Rejection; Guanidines; Humans; Kidney Transplantation; Methylprednisolone; Muromonab-CD3; Retrospective Studies | 1998 |
Correlation between Banff classification and reversal of acute renal rejection.
Topics: Acute Disease; Antilymphocyte Serum; Graft Rejection; Graft Survival; Guanidines; Humans; Immunosuppressive Agents; Kidney Transplantation; Methylprednisolone; Muromonab-CD3; Retrospective Studies; Time Factors | 1998 |
Effects of deoxyspergualin (DSG) administered in the chronic phase following kidney transplantation.
Topics: Chronic Disease; Follow-Up Studies; Graft Rejection; Guanidines; Humans; Immunosuppressive Agents; Kidney Transplantation; Methylprednisolone; Retrospective Studies; Time Factors | 1998 |
Impact of OKT3 treatment for steroid resistant rejection of renal allografts: the long-term outcome at a single center.
Topics: Actuarial Analysis; Acute Disease; Adult; Antilymphocyte Serum; Creatinine; Drug Resistance; Drug Therapy, Combination; Follow-Up Studies; Graft Rejection; Graft Survival; Guanidines; Humans; Immunosuppressive Agents; Kidney Transplantation; Methylprednisolone; Middle Aged; Muromonab-CD3; Retrospective Studies; Survival Analysis; Time Factors; Treatment Outcome | 1999 |
Conversion of renal transplant immunosuppression from tacrolimus (FK 506) to cyclosporine: a single center experience.
Topics: Adult; Azathioprine; Cyclosporine; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Guanidines; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Middle Aged; Muromonab-CD3; Retrospective Studies; Ribonucleosides; Tacrolimus; Treatment Outcome | 2000 |
Effect of Deoxyspergualin on the long-term outcome of renal transplantation.
Topics: Creatinine; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Survival; Guanidines; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Methylprednisolone; Retrospective Studies; Survivors; Time Factors; Treatment Outcome | 2000 |
Strategy for chronic rejection in recipient of living-related liver transplantation.
Topics: Alanine Transaminase; Aspartate Aminotransferases; Child, Preschool; Chronic Disease; Cyclosporine; Drug Therapy, Combination; Family; Female; Graft Rejection; Guanidines; Humans; Immunosuppressive Agents; Liver Transplantation; Living Donors; Lymphocytes; Male; Methylprednisolone; Reoperation; Tacrolimus | 2000 |
Therapeutic effect of 15-deoxyspergualin on acute graft rejection in canine liver transplantation.
Topics: Animals; Cyclosporine; Dogs; Drug Therapy, Combination; Graft Rejection; Guanidines; Immunosuppressive Agents; Liver Function Tests; Liver Transplantation; Methylprednisolone; Time Factors | 1994 |
Steroid-resistant late acute rejection after a living donor liver transplantation: case report and review of the literature.
Topics: Adult; Bilirubin; Enzymes; Graft Rejection; Guanidines; Humans; Immunosuppressive Agents; Liver Transplantation; Living Donors; Male; Methylprednisolone; Time Factors | 2007 |
Development of antibody mediated rejection shortly after acute cellular rejection in a pediatric kidney transplantation recipient.
Topics: Biopsy; Child; Glucocorticoids; Graft Rejection; Guanidines; Humans; Immunologic Factors; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Medication Adherence; Methylprednisolone; Plasma Exchange; Rituximab; Tissue Donors; Transplant Recipients; Treatment Outcome | 2018 |